At a cancer conference in Chicago in June last year, a little-known Chinese startup stunned researchers with early results showing its experimental gene therapy was abating an aggressive form of blood cancer in patients back home.
China sought to make an example of GlaxoSmithKline in a case that involved bribery of doctors and investigators and ended with guilty pleas and record penalties
When Mireille Gillings, founder and chairman of Huya Bioscience International first visited China in 2004, she saw a niche that could grow.
GlaxoSmithKline signs a deal to manufacture cut-price HIV drugs in China as the UK group rebuilds its presence after a corruption scandal.
The case is the biggest corruption scandal to hit a foreign company in China since the Rio Tinto affair in 2009, which resulted in four executives, including an Australian, being jailed for between 7-14 years.
A novel approach, using drugs from a South China company, instead of insecticides, may make it easier to eliminate malaria. But it is not without controversy.
A Chinese police investigation into drugmaker GlaxoSmithKline has discovered that alleged bribery of doctors in China was coordinated by the British company and was not the work of individual employees, state media reported on September 3...
China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery accusations against British drug maker GlaxoSmithKline. Corruption in China'...
A leaked document related to the recent G.S.K. scandal underscores the problems that can arise when major drug companies export their scientific development to emerging markets like China.
Selling pharmaceuticals and other health care products in China is increasingly fraught with peril. China is accusing GlaxoSmithKline of funnelling payments through travel agents to doctors, hospitals and government officials to bolster...
